期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

氯吡格雷无反应:从基因到临床 被引量：1

下载PDF
导出
摘要 数年前人们提出"氯吡格雷无反应"的现象,本文就近几年不断累积的临床和基础研究提出了新的认识和理解。
作者 赵树梅 李虹伟
机构地区 首都医科大学附属北京友谊医院心血管中心
出处 《心脏杂志》 CAS 2011年第5期664-666,共3页 Chinese Heart Journal
关键词 氯吡格雷无反应 基因因素 细胞因素 临床因素
分类号 R973 [医药卫生—药品]
  • 相关文献

参考文献15

  • 1白艳艳,王长谦.氯吡格雷抵抗研究进展[J].心脏杂志,2007,19(1):96-98. 被引量：5
  • 2刘普,马依彤.支架内血栓形成的原因及防治[J].心脏杂志,2008,20(1):108-110. 被引量：9
  • 3Combeseure C, Fontana P, Mallouk N, et al. Clinieal implications of elopidogrel non-response in eardiovaseular patients: a systematic review and meta-analysis [ J ]. J Thromb Haemost, 2010, 8 ( 5 ) :923 -933.
  • 4Bhatt DL, Scheiman J, Abraham NS, et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use : a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents[J]. J Am Coll Cardiol, 2008, 52(18) :1502- 1517.
  • 5Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary symtrome[ J ]. JAMA, 2009, 301 (9) :937 - 944.
  • 6Gilard M, Arnaud B, Cornily JC, et al. Influence of omcprazolc on the antiplatelct action of clopidogrel associated with aspirin : the randomized, dnuble-blind OCLA (Omeprazole CLopidogrcl Aspirin ) study[J]. JACC, 2008, 51 (3): 256-260.
  • 7Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel [J]. CMAJ, 2009, 180(7):713 -718.
  • 8Bhatt DL, Cryer BL, Contant CF, et al. Clopidogrel with or without omeprazole in coronary artery disease[ J ]. N Engl J Med, 2010, 363(20) :1909 - 1917.
  • 9Abraham NS, Hlatky MA, Antman EM, et al. ACCF/ACG/AHA 2010 expert consensus docunlent on the concomitant use of proton pump inhibitnrs and thienopyridines: a focused update of thee ACCF/ ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use[ J ].J Am Coll Cardiol, 2010, 56(24):2051 -2066.
  • 10Saw J, Brennan DM, Steinhubl SR, et al. l,ack of evidence of a clopidogre statin interaction in the CHARISMA trial [J]. J Am Coll Cardiol, 2007, 50 ( 4 ) :291 - 295.

二级参考文献34

  • 1韩雅玲,王守力,李毅,荆全民,马颖艳,王祖禄,王冬梅,栾波,王效增.急性冠状动脉综合征患者冠状动脉支架术前高负荷量氯吡格雷预治疗近期疗效[J].中国介入心脏病学杂志,2005,13(1):9-12. 被引量：53
  • 2调查协作组,霍勇.中国多中心药物洗脱支架急性或亚急性血栓的调查[J].中国介入心脏病学杂志,2005,13(3):131-134. 被引量：24
  • 3Clarke TA,Waskell LA.The Metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin[J].Drug Metab Dispos,2003,31(1):53-59.
  • 4Quinn MJ,Bhatt DL,Zidar F,et al.Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention[J].Am J Cardiol,2004,93(6):679-684
  • 5Nguyen TA,Diodati JG,Pharand C.Resistance to clopidogrel:A review of the evidence[J].J Am Coll Cardiol,2005,45(8):1157-1164
  • 6Xiao Z,Therous P.Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome[J].J Am Coll Cardiol,2004,43(11):1982-1988
  • 7Muller I,Besta F,Schulz C,et al.Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement[J].Thrombo Haemost,2003,89(5):783-787
  • 8Geiger J,Teichmann L,Grossmann R,et al.Monitoring of clopidogrel action:comparison of methods[J].Clin Chem,2005,51(6):957-965.
  • 9Lau WC,Waskell LA,Watkins PB,et al.Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation:a new drug-drug interaction[J].Circulation,2003,107(1):32-37.
  • 10Fontana P,Dupont A,Gandrille S,et al.Adenosine diphosphate -induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects[J].Circulation,2003,108(8):989-995.

共引文献11

同被引文献15

  • 1Farid NA, Smith RL, Gillespie TA, et al. The disposition of pra- sugrel, a novel thienopyridine, in humans[ J]. Drug Metab Dispos, 2007, 35(7) :1096 - 1104.
  • 2Jakubowski JA, Winters K J, Naganuma H, et al. Prasugrel: A no- vel thienopyridine antiplatelet agent [ J ]. Cardiovasc Drug Rev, 2007, 25(4) :357 -374.
  • 3Jakubowski JA, Winters K J, Naganuma H. Prasugrel: A novel thienopyridine antiplatelet agent [ J ]. Cardiovasc Drug Rev, 2007, 25 (4) :357 - 374.
  • 4Brandt JT, Payne CD, Wiviott SD, et al. A comparison of prasugrel and clopidogrel loading doses on platelet function: Magnitude of platelet inhibition is related to active metabolite formation [ J ]. Am Heart J, 2007,153(1) :e9 -el6.
  • 5Wallentin L, Varenhorst C, James S, et al. Prasugrel achieves greaterand faster and P2Y receptor-mediated platelet inhibition than clopi- dogrel due to more efficient generation of its active metabolite in as- pirin-treated patients with coronary artery disease [ J ]. Eur Heart J, 2008, 29(1) :21 -30.
  • 6Brandt JT, Payne CD, Wiviott SD, et al. A comparison of prasugrel and clopidogrelloading doses on platelet function: Magnitude of platelet inhibition is related to active metabolite formation [ J ]. Am Heart J, 2007, 153(1) :e9 -el6.
  • 7Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clo- pidogrel in patients with acute coronary syndromes [ J ]. N Eng J Med, 2007, 357(20):2001 -2015.
  • 8Wiviott SD, Braunwald E, McCabe CH, et al. Intensive oral anti- platelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a sub- analysis of a randomised trial [ J ]. Lancet, 2008, 371 (9621) : 1353 - 1363.
  • 9Donahoe SM, Stewart GC, McCabe CI-I, et al. Diabetes and mor- tality following acute coronary syndromes [ J ]. JAMA, 2007, 298 (7) :765 -775.
  • 10Motovska Z, Widimsky P, Petr R, et al. Factors influencing clopi- dogrel efficacy in patients with stable coronary artery disease under- going elective percutaneous coronary intervention: statin's advantage and the smoking "paradox" [J]. J Cardiovasc Pharmaco, 2009, 53 (5) :368 -372.

引证文献1

心脏杂志
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部